Cardinal Health price target raised after strong quarter
CNBC · RSS · · AI-summarised by FinFlash
Cardinal Health drew a higher price target after another quarter of strong profits, with the drug distributor also lifting its full-year earnings guidance. The combination of better-than-expected earnings and an upgraded outlook signals improving confidence in the company's earnings trajectory. For investors, the raised guidance and target point to continued earnings momentum in the drug distribution business.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.